{
    "clinical_study": {
        "@rank": "77282", 
        "acronym": "EnkAtomizer", 
        "arm_group": [
            {
                "arm_group_label": "Working channel", 
                "arm_group_type": "Experimental", 
                "description": "Patients will receive local anaesthetics via the working channel of the bronchoscope."
            }, 
            {
                "arm_group_label": "Enk Fiberoptic Atomizer", 
                "arm_group_type": "Experimental", 
                "description": "Patients will receive the local anaesthetics for the flexible bronchoscopy via the nebulizer Enk Fiberoptic Atomizer."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this prospective study is to examine the benefits und risks of administration of\n      local anaesthetics with a special atomizing set (Enk Fiberoptic Atomizer, Cook Medical)\n      during flexible bronchoscopy."
        }, 
        "brief_title": "Effect of the EnkFiberoptic Atomizer Set on Usage of Anaesthetics During the Bronchoscopy", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Administration of Local Anaesthetics With a Special Atomizing Set Durching Fexible Bronchoscopy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  bronchoscopy with transbronchial biopsy or cryobiopsy indicated for  diagnostic\n             purposes (suspected lung cancer, interstitial lung disease, unexplained pulmonary\n             opacities)\n\n          -  hospitalized patients\n\n          -  patients aged 18 years or above\n\n          -  written informed consent prior to study participation\n\n        Exclusion Criteria:\n\n          -  known allergy to local anesthetics, midazolam or propofol, known epilepsy, known\n             severe neurological or psychiatric disorder, hemodynamic instability with need for\n             vasopressor therapy, acute or chronic decompensated heart failure, respiratory\n             failure with the need for oxygen supplementation of more than 2 l per minute at rest\n             (pO2 > 55 mmHg) or pCO2 > 50 mmHg at ambient air, known upper airway anomalies,\n             surgery or irradiation of the upper airways in the past, contraindication for\n             transbronchial biopsy as published by international guidelines, e. g. bleeding\n             disorders or severe pulmonary hypertension\n\n          -  women, who are pregnant or breastfeeding\n\n          -  alcohol or drug abuse\n\n          -  expected non-compliance\n\n          -  patients unwilling or unable to give informed consent, patients with limited ability\n             to comply with instructions for this study\n\n          -  Participation on another clinical trial within the last 3 months\n\n          -  subjects who are committed to an institution and/or penitentiary by judicial or\n             official order.\n\n          -  employees of the investigator cooperation companies."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01969045", 
            "org_study_id": "13-103", 
            "secondary_id": "EK 222/13"
        }, 
        "intervention": [
            {
                "arm_group_label": "Enk Fiberoptic Atomizer", 
                "description": "Nebulization of local anesthetics with the Enk Fiberoptic Atomizer by Cook Medical during the felxible bronchoscopy", 
                "intervention_name": "Enk Fiberoptic Atomizer", 
                "intervention_type": "Device", 
                "other_name": "Enk Fiberoptic Atomizer Set, Cook Medical"
            }, 
            {
                "arm_group_label": "Working channel", 
                "description": "Standard procedure: Administration of local anesthetics via the working channel of the bronchoscope during the felxible bronchoscopy", 
                "intervention_name": "bronchoscope", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics, Local", 
                "Anesthetics"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "felxible bronchoscopy", 
            "anaesthetics", 
            "transcutaneous pCO2", 
            "capillary pCO2"
        ], 
        "lastchanged_date": "October 23, 2013", 
        "location": {
            "contact": {
                "email": "tobmueller@ukaachen.de", 
                "last_name": "Tobias M\u00fcller, Dr. med.", 
                "phone": "+49 241 80 36470"
            }, 
            "contact_backup": {
                "email": "asudhoff@ukaachen.de", 
                "last_name": "Angela Sudhoff, M.Sc.", 
                "phone": "+49 241 80 37429"
            }, 
            "facility": {
                "address": {
                    "city": "Aachen", 
                    "country": "Germany", 
                    "state": "North Rhine-Westphalia", 
                    "zip": "52074"
                }, 
                "name": "Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, RWTH Aachen University Hospital"
            }, 
            "investigator": {
                "last_name": "Tobias M\u00fcller, Dr. med.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of the EnkFiberoptic Atomizer Set on Usage of Anaesthetics During the Bronchoscopy", 
        "overall_contact": {
            "email": "tobmueller@ukaachen.de", 
            "last_name": "Tobias M\u00fcller, Dr. med.", 
            "phone": "+49 241 80 36470"
        }, 
        "overall_contact_backup": {
            "email": "asudhoff@ukaachen.de", 
            "last_name": "Angela Sudhoff, M.Sc.", 
            "phone": "+49 241 80 37429"
        }, 
        "overall_official": {
            "affiliation": "Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, RWTH Aachen University Hospital", 
            "last_name": "Tobias M\u00fcller, Dr. med.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Valdiation of the total amount of administered propofol (mg) during the fexible bronchoscopy.\nUsage of sedatives other than propofol (midazolam), total amount of administered lidocaine, duration of bronchoscopy.", 
            "measure": "Amount of anaesthetics during fexible bronchoscopy", 
            "safety_issue": "No", 
            "time_frame": "one hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01969045"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Determination of:\nmaximum transcutaneous pCO2 during bronchoscopy, mean transcutaneous pCO2 during bronchoscopy, capillary pCO2 immediately after bronchoscopy and 2 hours later, time to Aldrete Score of at least 9 after procedure", 
            "measure": "pCO2", 
            "safety_issue": "No", 
            "time_frame": "two hours"
        }, 
        "source": "RWTH Aachen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "RWTH Aachen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}